SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-092065
Filing Date
2022-03-31
Accepted
2022-03-31 17:16:12
Documents
13
Period of Report
2022-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d309564d8k.htm   iXBRL 8-K 25156
2 EX-10.1 d309564dex101.htm EX-10.1 44281
  Complete submission text file 0001193125-22-092065.txt   207720

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA freq-20220325.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20220325_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20220325_pre.xml EX-101.PRE 11708
7 EXTRACTED XBRL INSTANCE DOCUMENT d309564d8k_htm.xml XML 3472
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 22794210
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences